EUVIMEDEUVIMED entdecken
Open Access · CC0

Protection induced in pigs previously infected by the non-virulent strain 1330 of Streptococcus suis serotype 2 is not due to the secretion of the bacteriocin suicin

Samantha J Hau iD, Nahuel Fittipaldi, Servane Payen, Daniel Grenier, Daniel W Nielsen, Susan L Brockmeier, Marcelo Gottschalk

PLOS One · 2025

DOI: 10.1371/journal.pone.0323370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Samantha J Hau und 6 weiteren Autor:innen. Beteiligte Einrichtung: Virus and Prion Research Unit, National Animal Disease Center, ARS, USDA, Ames, Iowa, United States of America. Hauptthemen laut MEDLINE: Streptococcus suis, Bacteriocins, Streptococcal Infections, Swine Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus suis is a systemic pathogen of swine and imposes a significant economic burden on the swine industry. Disease with S. suis is controlled with antibiotic treatment and vaccination with inactivated vaccines, which can be derived from the strains circulating on the farm. Inactivated vaccines have shown mixed results with minimal data supporting reductions in morbidity and mortality following their use. With increasing restrictions on antibiotic use and increasing concerns surrounding antimicrobial resistance, alternatives to antibiotics or novel, highly effective vaccines are needed for treating or preventing disease with S. suis . Bacteriocins are a potential alternative to antibiotics, as bacteriocins are antimicrobial peptides produced by bacteria. However, the use of bacteriocins to limit pathogenic S. suis remains relatively under-examined. Live vaccines are a potential novel and effective method of preventing disease, as they provide competition for pathogenic strains and would limit pathogenic strain colonization while stimulating a protective immune response. This study investigated the use of an avirulent, bacteriocin producing isolate of S. suis (90–1330) as an intranasal vaccine and evaluated the role of the bacteriocin by comparing protection to animals inoculated with a mutant lacking bacteriocin production (90–1330Δ suicin ). Animals were protected from systemic disease when challenged with a virulent isolate 21 days after inoculation with either 90–1330 or 90–1330Δ suicin but were not protected when challenged 3 days after inoculation. Evaluation of antibody titers showed increased titers 21 days post-inoculation, and the humoral response was likely providing systemic protection. Although 90–1330 was unable to protect animals challenged 3 days post-inoculation, the strain should be considered a good candidate for vaccine development. S. suis 90–1330 was able to induce a protective immune response with a single intranasal inoculation and bacteriocin production may be able to contribute to protection when animals have a lower exposure dose, as in a production setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus suisBacteriocinsStreptococcal InfectionsSwine DiseasesStreptococcal VaccinesAnimalsSwineSerogroup

Substanzen

BacteriocinsStreptococcal Vaccines

Autor:innen und Institutionen

  • Virus and Prion Research Unit, National Animal Disease Center, ARS, USDA, Ames, Iowa, United States of America.
  • Groupe de recherche sur les maladies infectieuses en production animale, Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, QC, Canada.
  • Centre de Recherche en Infectiologie Porcine et Avicole (CRIPA), Fonds de Recherche du Québec - Nature et Technologies (FQRNT), Saint-Hyacinthe, QC, Canada.
  • Groupe de Recherche en Écologie Buccale (GREB), Faculté de Médecine Dentaire, Université Laval, Quebec City, QC, Canada.
  • Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, ARS, USDA, Ames, Iowa, United States of America.

ORCID-Profile: Samantha J Hau

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Hau, S. J., Fittipaldi, N., Payen, S., Grenier, D., Nielsen, D. W., Brockmeier, S. L., & Gottschalk, M. (2025). Protection induced in pigs previously infected by the non-virulent strain 1330 of Streptococcus suis serotype 2 is not due to the secretion of the bacteriocin suicin. PLOS One. https://doi.org/10.1371/journal.pone.0323370

Vancouver

Hau SJ, Fittipaldi N, Payen S, Grenier D, Nielsen DW, Brockmeier SL, et al. Protection induced in pigs previously infected by the non-virulent strain 1330 of Streptococcus suis serotype 2 is not due to the secretion of the bacteriocin suicin. PLOS One. 2025. doi:10.1371/journal.pone.0323370

BibTeX
@article{Hau2025,
  author = {Hau, Samantha J and Fittipaldi, Nahuel and Payen, Servane and Grenier, Daniel and Nielsen, Daniel W and Brockmeier, Susan L and Gottschalk, Marcelo},
  title = {Protection induced in pigs previously infected by the non-virulent strain 1330 of Streptococcus suis serotype 2 is not due to the secretion of the bacteriocin suicin},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0323370}
}
Kostenlos starten →